FRE.DE StockTwits Mentions
Track FRE.DE's AI-powered predictions, market trends, and investment insights.
You don't hold FRE.DE in your mock portfolio yet.
Track FRE.DE's AI-powered predictions, market trends, and investment insights.
You don't hold FRE.DE in your mock portfolio yet.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get StartedThe valuation metrics provided (PE of 13.7 and EPS of 2.68) suggest Fresenius is reasonably valued versus many healthcare peers, implying the market is pricing in modest, not high, growth. The EPS level indicates the business is solidly profitable, but the recent price decline and discount to its 200‑day moving average hint that investors are cautious about the earnings trajectory or structural challenges. Without evidence of accelerating revenue or margin expansion, the financial picture appears stable but not clearly improving.
The stock is trading at €36.71, about 21–22% below its 200‑day moving average of €46.64, which is a clear sign of a sustained downtrend. A 11.0% decline over the last month reinforces negative momentum and indicates persistent selling pressure. While the valuation does not look stretched, the technical setup currently points to continued weakness rather than an imminent reversal.
Website traffic of about 70,580 visitors per month and flat job openings (19, up 0.0% MoM) point to a relatively stable but not expanding operational footprint in the near term. Social media followership is slightly declining across major platforms, suggesting softening engagement and brand momentum. Overall, alternative data do not indicate strong growth or rising interest that could counteract the current negative stock trend.
Combining the technical downtrend with soft alternative data and only moderately attractive valuation, the overall picture for Fresenius SE & Co. KGaA skews bearish in the near term. While the company remains profitable and not excessively valued, current signals do not yet indicate a clear catalyst for a sustained recovery. Until earnings growth or operational indicators improve, the risk/reward appears tilted to the downside or at best range‑bound.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Unlock comprehensive alternative data signals to make better investment decisions
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
Web Traffic
72,194
Twitter Followers
14,571
Instagram Followers
15,798
YouTube Subscribers
5,990
LinkedIn Followers
114,641
Job Postings
17
LinkedIn Employees
2,080
News Mentions
0
Key Metrics